Expression analysis of putative stem cell markers in human benign and malignant prostate

Andrey V. Ugolkov, Laurie J. Eisengart, Chunyan Luan, Ximing J. Yang

Research output: Contribution to journalArticlepeer-review

55 Scopus citations


Background Stem cells were suggested to be present in human prostate cancer as a small population of distinct cells, which may contribute to carcinogenesis, tumor recurrence, and chemoresistance. To identify potential prostatic stem cells, we analyzed the expression of several potential stem cell markers in benign prostate and prostatic adenocarcinoma. Methods CD44, CD133, Oct4, SOX2, and EZH2 expression was detected by immunohistochemical (IHC) staining using tissue microarray assays (TMA) composed of benign (non-neoplastic) prostatic tissue, high grade prostatic intraepithelial neoplasia (HGPIN), and prostatic adenocarcinoma. Positive staining was defined as 1+ (<10%), 2+ (10-50%), or 3+ (>50%). Results We found CD44 staining in 97% and 72% of benign + HGPIN and malignant lesions, respectively. CD133 staining was detected in a small fraction (4 of 67) of prostate carcinomas. We found that Oct4 nuclear expression was strongly associated with benign lesions and HGPIN but not prostate cancer (P < 0.05). In most cases, nuclear expression of EZH2 and SOX2 was detected in less than 10% of cells in non-neoplastic prostate glands, HGPINs or prostate adenocarcinomas. Moreover, 27 of 33 SOX2 1+ prostate cancers were also EZH2 1+, whereas all 33 of these cases were CD44+. Conclusions Expression of CD44 and Oct4 identified large populations of benign and malignant cells in the prostate, which did not fit the definition of stem cells as a small fraction of the total cell population. Our results suggest that combined expression of embryonic stem cell markers EZH2 and SOX2 might identify potential cancer stem cells as a minor (<10%) subgroup in CD44+ prostatic adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)18-25
Number of pages8
Issue number1
StatePublished - Jan 1 2011


  • EZH2
  • SOX2
  • prostate cancer
  • stem cells

ASJC Scopus subject areas

  • Oncology
  • Urology


Dive into the research topics of 'Expression analysis of putative stem cell markers in human benign and malignant prostate'. Together they form a unique fingerprint.

Cite this